Stein H. Annexstad

Biography

  Mr. Stein Holst Annexstad serves as a Managing Director at Centennial ASA. Mr. Annexstad serves as a Managing Director at Anticancer Therapeutic Inventions AS. He serves as a Managing Director and the Chief Executive Officer at Trinity Capital AS. He has top management experience as a Managing Director at Nycomed AS and as an Acting Group Managing Director and the Chief Executive Officer for Nycomed Amersham. He has also held a number of positions with Dyno Industrier ASA. He served as a Partner at NorgesInvestor AS. He has worked as a Partner and a Managing Director at ISCO Group AS and Annexstad Hartvig Wennberg AS. He was among the founders of Investor Norway AS. He serves as the Chairman of the Board of Johan G. Olsen and Biotec ASA. He has held a series of Board Chairman Positions in Norwegian industry and education institutions, including at Fokus Bank ASA, Norsk Medisinaldepot AS, Norwegian School of Management BI and Sintef. He has been Chairman of BerGenBio AS since January 16, 2017. He served as the Chairman of Investinor AS. He served as the Chairman and Deputy Chairman at Algeta ASA. He served as the Chairman and Director at Luxo ASA. He served as the Chairman and Director of Mole Genetics AS. He has been a Non-Executive Director at BerGenBio AS since February 01, 2016. He has been a Director of Algeta ASA since October 2000, Intelecom Group AS since 1999 and Intelecom Group AS since 1999. He served as a Director of Cermaq ASA. He serves as a Member of Nomination Committee at Ericsson Television AS. He served as a Member of Election Committee and Member of Nominating Committee at NEL ASA. Mr. Annexstad holds a Bachelor degree in Business Administration from the Norwegian School of Economics and Business Administration.

Research Interest

Bussiness managemnt